After the publication of our December 2007 supplement, “Health-related Quality of Life in Rheumatoid Arthritis,” the Editors learned that several authors were not given the opportunity to review the final proofs of their manuscripts. As a result, the following errors were subsequently identified. First, the co-author’s name was inadvertently omitted from the Introduction. The correct byline for the Introduction should read: Daniel E. Furst, MD, and Dinesh Khanna, MD.
Second, in the article “Generic Quality-of-life Assessment in Rheumatoid Arthritis,” by Tugwell, et al (Am J Manag Care. 2007;13[suppl 9]:S224-S236), some of the indicators for Health Dimension and Psychometric Properties were missing from Table 1; some data in Table 3 were incorrect; and the reference numbers in Figures 1a and 1b were misnumbered. The corrected tables and figures appear on the following pages (see pages 235-238).
Finally, due to the extent of the errors in the article by Strand et al, “Improved Health-related Quality of Life With Effective Disease-modifying Antirheumatic Drugs: Evidence From Randomized Controlled Trials,” we are reprinting a corrected version of this article in this issue (see pages 239-253).
Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending
August 19th 2025Hospital accountable care organization (ACO) participation did not impact emergency department admission rates, length of stay, or costs, suggesting limited effectiveness in reducing spending for unplanned admissions and challenging hospital-led ACO cost-saving strategies.
Read More
Assessment of Variation in Ambulatory Cardiac Monitoring Among Commercially Insured Patients
August 13th 2025Ambulatory cardiac monitors’ clinical and economic outcomes vary; one long-term continuous monitor brand showed greater arrhythmia diagnosis, fewer retests and cardiovascular events, and lower health care resource use and costs.
Read More
Care Quality Metrics in Medicare During COVID-19 Pandemic
August 12th 2025Medicare Advantage outperformed traditional Medicare on clinical quality measures before and during the COVID-19 pandemic; mid-pandemic, however, traditional Medicare narrowed the gap on some in-person screenings.
Read More